Sriven Pharmachem India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 43.45 Cr
as on 10-12-2024
- Satisfied Charges ₹ 1.75 Cr
as on 10-12-2024
- Revenue 112.69%
(FY 2023)
- Profit 67.51%
(FY 2023)
- Ebitda 42.31%
(FY 2023)
- Net Worth 62.33%
(FY 2023)
- Total Assets 473.36%
(FY 2023)
About Sriven Pharmachem India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹43.45 Cr. The company has closed loans amounting to ₹1.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suryanarayana Rudraraju and Krishnaveni Rudraraju serve as directors at the Company.
- CIN/LLPIN
U24233TG2015PTC097894
- Company No.
097894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sriven Pharmachem India Private Limited offer?
Sriven Pharmachem India Private Limited offers a wide range of products and services, including API Intermediate, Pyridine Derivatives, Chemical Compound, Insecticides and Pesticides, Pesticide Intermediate, Organic and Inorganic Solvents, Inorganic Chemicals.
Who are the key members and board of directors at Sriven Pharmachem India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryanarayana Rudraraju  | Director | 05-Mar-2015 | Current |
| Krishnaveni Rudraraju | Additional Director | 08-Dec-2022 | Current |
Financial Performance of Sriven Pharmachem India.
Sriven Pharmachem India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 112.69% increase. The company also saw a substantial improvement in profitability, with a 67.51% increase in profit. The company's net worth Soared by an impressive increase of 62.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sriven Pharmachem India?
In 2023, Sriven Pharmachem India had a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Aug 2024 | ₹0.99 M | Open |
Others Creation Date: 16 Jul 2024 | ₹1.01 M | Open |
Others Creation Date: 12 Apr 2024 | ₹1.51 M | Open |
How Many Employees Work at Sriven Pharmachem India?
Sriven Pharmachem India has a workforce of 79 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sriven Pharmachem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sriven Pharmachem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
